Ansun BioPharma Revenue and Competitors
Estimated Revenue & Valuation
- Ansun BioPharma's estimated annual revenue is currently $4.8M per year.
- Ansun BioPharma's estimated revenue per employee is $155,000
Employee Data
- Ansun BioPharma has 31 Employees.
- Ansun BioPharma grew their employee count by -16% last year.
Ansun BioPharma's People
| Name | Title | Email/Phone |
|---|
Ansun BioPharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Ansun BioPharma?
Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics. Our lead product, DAS181, is a multi-function sialidase fusion protein for host-cellprotection in respiratory virus infection, including parainfluenza, influenza and COVID19,. We are also advancing several additional programs in oncology and autoimmune diseases using our sialidase platform technology.
keywords:N/A
N/A
Total Funding
31
Number of Employees
$4.8M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.1M | 31 | N/A | N/A |
#2 | $6.3M | 31 | 7% | N/A |
#3 | $6.2M | 31 | -35% | N/A |
#4 | $3.6M | 31 | 11% | N/A |
#5 | $4.8M | 31 | 0% | N/A |